MeiraGTx Holdings (MGTX) FCF Margin (2019 - 2025)
MeiraGTx Holdings' (MGTX) quarterly FCF Margin came in at 61.51% in Q4 2025, up 17602.0% YoY from N/an in Q4 2024, and up 101.97% on a QoQ basis from 3128.05% in Q3 2025.
MeiraGTx Holdings (MGTX) FCF Margin (2019 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 7 years of FCF Margin data on file, last reported at 61.51% in Q4 2025.
- Quarterly FCF Margin rose 17602.0% year-over-year to 61.51% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 49.76% (up 27913.0% YoY) and the FY2025 annual result came in at 61.66%, up 26723.0% from the prior year.
- FCF Margin grew to 61.51% in Q4 2025, from 3128.05% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 1155.81% in Q4 2022 to a low of 8189.72% in Q2 2024.
- A 5-year average of 1143.15% and a median of 388.58% in 2022 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2024 — FCF Margin tumbled 722963 bps — and 2025, when it soared 696487 bps.
- Tracing MGTX's FCF Margin over 5 years: stood at 26.33% in 2021, then soared by 4489 bps to 1155.81% in 2022, then slumped by 169 bps to 801.03% in 2023, then jumped by 86 bps to 114.51% in 2024, then jumped by 154 bps to 61.51% in 2025.
- The last three FCF Margin figures came in at 61.51% (Q4 2025), 3128.05% (Q3 2025), and 1224.84% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - | 61.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 61.51% |
| Sep 30, 2025 | -3,128.05% |
| Jun 30, 2025 | -1,224.84% |
| Dec 31, 2024 | -114.51% |
| Sep 30, 2024 | -236.04% |
| Jun 30, 2024 | -8,189.72% |
| Mar 31, 2024 | -5,180.63% |
| Dec 31, 2023 | -801.03% |
| Sep 30, 2023 | -212.60% |
| Jun 30, 2023 | -960.08% |
| Mar 31, 2023 | -1,379.63% |
| Dec 31, 2022 | 1,155.81% |
| Sep 30, 2022 | 116.76% |
| Jun 30, 2022 | -388.58% |
| Mar 31, 2022 | -368.51% |
| Dec 31, 2021 | -26.33% |
| Sep 30, 2021 | -418.65% |
| Jun 30, 2021 | -524.55% |
| Mar 31, 2021 | 99.76% |
| Dec 31, 2020 | -992.00% |